Browse grants

National Institutes of Health · Up to $1M

Open to U.S. universities, research institutions, nonprofits, foreign organizations, and certain government/tribal entities. This NIH R01 funds preclinical mouse-model testing of repurposed or investigational drugs — alone or with non-drug interventions — for Alzheimer's disease and related dementias. Awards up to about $1,000,000.

National Institutes of Health · Up to $500K

Open to U.S. schools and colleges of nursing and other research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH P20 funds new research centers that build nursing-led, community-partnered research infrastructure and pilot studies. Awards up to about $500,000.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, foreign organizations, and certain government/tribal entities. This NIH X01 provides access to TOPMed genomic and multi-omics data resources to study heart, lung, blood, and sleep disorders — it offers data generation, not direct funding. Aimed at researchers doing functional-genomics and mechanism studies.

National Institutes of Health · Up to $2.1M

Open to U.S. research institutions and universities, nonprofits, and certain government/tribal organizations; foreign organizations cannot apply, and (as of May 2025) projects with foreign subawards are ineligible. This NIH U2C-TL1 funds institutional networks that recruit and train researchers in kidney, urologic, and hematologic disease research. Awards up to about $2,100,000.

National Institutes of Health · Amount varies

Open to eligible NIGMS-funded investigators and new investigators at U.S. institutions; foreign organizations are not eligible, and projects with foreign subawards are excluded. This NIH R35 (MIRA) gives an investigator stable, flexible single-grant support for their lab's research within the NIGMS mission, rather than project-by-project funding. Early-stage investigators should use the separate ESI MIRA notice.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R61/R33 funds mechanistic clinical research on how mind-and-body interventions (e.g., meditation, yoga, acupuncture) affect emotional well-being and whole-person health, in two milestone-tied phases. Strong preliminary data are expected.

National Institutes of Health · Up to $500K

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R01 funds groundbreaking, high-impact Down syndrome research across any relevant topic, with no preliminary data required. Awards up to about $500,000.

National Institutes of Health · Up to $200K

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R21 funds exploratory, higher-risk Down syndrome research — feasibility studies, novel methods, or new applications of existing techniques. Awards up to about $200,000.

National Institutes of Health · Amount varies

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R61/R33 funds milestone-driven development of clinical trials to treat co-occurring health conditions in people with Down syndrome — up to two years of planning followed by up to three years of trial support. Clinical trials are required.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R21 funds projects that improve clinical-trial readiness for rare diseases — developing biomarkers and outcome measures, or characterizing a disease's course to enable future trials. Award size follows standard R21 limits.

National Institutes of Health · Up to $3M

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH UG3/UH3 funds discovery and development of interventions — medications and devices — to prevent and treat substance use disorders and overdose, including preclinical and clinical studies. Awards up to about $3,000,000.

National Institutes of Health · Up to $500K

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 funds development of non-invasive or minimally invasive technologies to image the human olfactory system at high resolution. Awards up to about $500,000; multidisciplinary teams are encouraged.

National Institutes of Health · Amount varies

Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.

National Institutes of Health · Amount varies

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH/NCI R21 funds early-stage, exploratory research on cancer control — prevention behaviors, screening, etiology, and novel methods. Award size follows standard R21 limits.

National Institutes of Health · Amount varies

Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH DP1 (Avant-Garde/Avenir) funds high-risk, high-reward research on HIV and substance use — basic, clinical, translational, or implementation science. It backs bold, transformative ideas; award size follows the DP1 mechanism.

National Institutes of Health · Up to $400K

This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.

National Institutes of Health · Up to $300K

This NIH UG3/UH3 cooperative agreement funds community-based participatory research that tests population-level interventions to improve oral health by addressing social and chronic-disease risk factors through cross-sector community partnerships. The award ceiling is up to about $300,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.

National Institutes of Health · Amount varies

The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.

Centers for Disease Control and Prevention - ERA · Amount varies

This CDC health research opportunity (RFA-IP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or program specifics. Because it appears aimed at existing grantees, check with CDC about eligibility if you have not held a prior award.

Centers for Disease Control and Prevention - ERA · Amount varies

This CDC health research opportunity (RFA-OE-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or detailed requirements. Since it appears intended for existing grantees, confirm eligibility with CDC before applying as a new applicant.